Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient

Terlipressin is used commonly in the management of hepatorenal syndrome and acute variceal bleeding. Like its parent compound vasopressin, it is also notorious for its ischemic complications. Terlipressin-induced ischemic complications can virtually affect any part of the body, but the incidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarma, Phulen, Muktesh, Gaurav, Dhaka, Narender, Ruhela, Rakesh, Mishra, Abhishek, Singh, Rahul, Sinha, Saroj K., Medhi, Bikash, Kochhar, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642133/
https://www.ncbi.nlm.nih.gov/pubmed/29081628
http://dx.doi.org/10.4103/jpp.JPP_42_17
_version_ 1783271318986162176
author Sarma, Phulen
Muktesh, Gaurav
Dhaka, Narender
Ruhela, Rakesh
Mishra, Abhishek
Singh, Rahul
Sinha, Saroj K.
Medhi, Bikash
Kochhar, Rakesh
author_facet Sarma, Phulen
Muktesh, Gaurav
Dhaka, Narender
Ruhela, Rakesh
Mishra, Abhishek
Singh, Rahul
Sinha, Saroj K.
Medhi, Bikash
Kochhar, Rakesh
author_sort Sarma, Phulen
collection PubMed
description Terlipressin is used commonly in the management of hepatorenal syndrome and acute variceal bleeding. Like its parent compound vasopressin, it is also notorious for its ischemic complications. Terlipressin-induced ischemic complications can virtually affect any part of the body, but the incidence of serious complications is less than its parent compound vasopressin. Here, we report a case of terlipressin-induced peripheral ischemic gangrene in a diabetic male, which ultimately led to death of the patient.
format Online
Article
Text
id pubmed-5642133
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56421332017-10-27 Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient Sarma, Phulen Muktesh, Gaurav Dhaka, Narender Ruhela, Rakesh Mishra, Abhishek Singh, Rahul Sinha, Saroj K. Medhi, Bikash Kochhar, Rakesh J Pharmacol Pharmacother Case Report Terlipressin is used commonly in the management of hepatorenal syndrome and acute variceal bleeding. Like its parent compound vasopressin, it is also notorious for its ischemic complications. Terlipressin-induced ischemic complications can virtually affect any part of the body, but the incidence of serious complications is less than its parent compound vasopressin. Here, we report a case of terlipressin-induced peripheral ischemic gangrene in a diabetic male, which ultimately led to death of the patient. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5642133/ /pubmed/29081628 http://dx.doi.org/10.4103/jpp.JPP_42_17 Text en Copyright: © 2017 Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Sarma, Phulen
Muktesh, Gaurav
Dhaka, Narender
Ruhela, Rakesh
Mishra, Abhishek
Singh, Rahul
Sinha, Saroj K.
Medhi, Bikash
Kochhar, Rakesh
Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
title Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
title_full Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
title_fullStr Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
title_full_unstemmed Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
title_short Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
title_sort terlipressin-induced peripheral ischemic gangrene in a diabetic patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642133/
https://www.ncbi.nlm.nih.gov/pubmed/29081628
http://dx.doi.org/10.4103/jpp.JPP_42_17
work_keys_str_mv AT sarmaphulen terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT mukteshgaurav terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT dhakanarender terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT ruhelarakesh terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT mishraabhishek terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT singhrahul terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT sinhasarojk terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT medhibikash terlipressininducedperipheralischemicgangreneinadiabeticpatient
AT kochharrakesh terlipressininducedperipheralischemicgangreneinadiabeticpatient

Ejemplares similares